Major tech players commit unprecedented capital to AI development as practical limitations emerge. OpenAI debuts autonomous agents, Tesla allocates $25 billion to AI research surpassing traditional automakers, and SpaceX pursues a massive investment in coding startup Cursor. Meanwhile, generative drug discovery reveals gaps between AI's creative output and real-world validation capabilities.

Thursday, April 23, 2026 — 976 words / ~6.5 min

Today's Top Stories:

  1. OpenAI's New Bots Work Unsupervised While You Sleep
  2. Tesla's $25B AI Bet Dwarfs Every Automaker's R&D Combined
  3. SpaceX Bets $60B on AI Startup Nobody's Heard Of
  4. SpaceX's $60B Cursor Bid Just Made Two VCs Unfathomably Rich
  5. AI Designed 40 Million Drug Candidates and Can't Tell Which Ones Work